Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome
Recruiting · NCT06519162 · Observational (researchers observe without assigning treatment) · Lead sponsor: Chungnam National University Hospital
View the official record on ClinicalTrials.gov →What this trial is about
In this study, we aim to identify gut microbiomes specific to patients with chronic refractory liver disease and to conduct a gut-liver axis study on the pathogenesis and disease progression.
Who can take part
Age range
19 Years and older
Sex
All (male and female)
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Adults aged 19 years and older diagnosed with autoimmune hepatitis, primary biliary cholangitis, primary sclerosing cholangitis, non-alcoholic fatty liver disease, or liver abscess, who have consented to participate in this study at Chungnam National University Hospital.
- Adults aged 19 years and older, who are cohabitants of patients diagnosed with autoimmune hepatitis, primary biliary cholangitis, primary sclerosing cholangitis, non-alcoholic fatty liver disease, or liver abscess, and have consented to participate in this study at Chungnam National University Hospital.
- B. Exclusion
Exclusion criteria
- Individuals under the age of 19.
- Patients or guardians who do not consent to participate in the study
Where it is running
1 location listed.
- Chungnam National University Hospita - Daejeon, Jung-gu, South Korea